Genmab reported DKK550M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Amgen AMGN:US USD 37.16B 1.46B
AstraZeneca AZN:LN USD 23.68B 3.47B
Bayer BAYN:GR EUR 39.46B 1.4B
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Fresenius Medical Care FME:GR EUR 12.41B 930M
Galapagos GLPG:NA EUR 15.76M 1.12M
Genmab GEN:DC DKK 550M 4M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Hikma Pharmaceutical HIK:LN USD 1.41B 689M
Insmed INSM:US USD 807.48M 366K
Lonza Group LONN:SW CHF 1.95B 287M
Merck MRK:GR EUR 9.27B 119M
Novartis NOVN:VX USD 21.24B 2.55B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX 22.37B 6.29B
William Demant Holding WDH:DC DKK 4.88B 470M